Literature DB >> 19041823

Fine-needle aspiration of the thyroid: today and tomorrow.

Zubair W Baloch1, Virginia A LiVolsi.   

Abstract

This review describes the morphological features of the common thyroid lesions that are sampled by fine-needle aspiration (FNA), including hyperplastic (adenomatous, adenomatoid) nodules, inflammatory and autoimmune conditions (lymphocytic thyroiditis), and benign and malignant neoplasms. For the last category of lesions, the cytological features are described and the differential diagnoses are discussed. Finally, an assessment of modern techniques such as immunohistochemistry and molecular analyses is given with emphasis on their validity for FNA samples as well as the pitfalls that are encountered in their use.

Entities:  

Mesh：

Year:  2008        PMID： 19041823     DOI： 10.1016/j.beem.2008.09.011

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN： 1521-690X            Impact factor:   4.690


  10 in total

Review 1.  Cytopathologic diagnosis of fine needle aspiration biopsies of thyroid nodules.

Authors:  Evangelos P Misiakos; Niki Margari; Christos Meristoudis; Nickolas Machairas; Dimitrios Schizas; Konstantinos Petropoulos; Aris Spathis; Petros Karakitsos; Anastasios Machairas
Journal:  World J Clin Cases       Date:  2016-02-16       Impact factor: 1.337

2.  Hashimotos Thyroiditis with Coexistent Papillary Carcinoma and Non-hodgkin Lymphoma-thyroid.

Authors:  Ks Jayaprakash; Hl Kishanprasad; P Hegde; R Chandrika
Journal:  Ann Med Health Sci Res       Date:  2014-03

Review 3.  A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.

Authors:  Cristina Romei; Raffaele Ciampi; Rossella Elisei
Journal:  Nat Rev Endocrinol       Date:  2016-02-12       Impact factor: 43.330

4.  The Immunocytochemistry Is a Valuable Tool in the Diagnosis of Papillary Thyroid Cancer in FNA's Using Liquid-Based Cytology.

Authors:  Kalliopi Pazaitou-Panayiotou; Nikolas Mygdakos; Kyriaki Boglou; Anastasia Kiziridou; Alexandra Chrisoulidou; Chariklia Destouni
Journal:  J Oncol       Date:  2010-10-27       Impact factor: 4.375

5.  RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.

Authors:  Cristina Romei; Rossella Elisei
Journal:  Front Endocrinol (Lausanne)       Date:  2012-04-11       Impact factor: 5.555

6.  microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer.

Authors:  Gianna Carvalheira; Bruno Heidi Nozima; Janete Maria Cerutti
Journal:  Oncotarget       Date:  2015-09-29

7.  Expression Profiles of miR-22-5p and miR-142-3p Indicate Hashimoto's Disease and Are related to Thyroid Antibodies.

Authors:  Olivia Trummer; Ines Foessl; Natascha Schweighofer; Edi Arifi; Christoph W Haudum; Sharmaine Reintar; Stefan Pilz; Verena Theiler-Schwetz; Christian Trummer; Andreas Zirlik; Albrecht Schmidt; Caterina Colantonio; Ewald Kolesnik; Nicolas Verheyen; Thomas R Pieber; Barbara Obermayer-Pietsch
Journal:  Genes (Basel)       Date:  2022-01-19       Impact factor: 4.096

8.  CD11c+ B Cells Participate in the Pathogenesis of Graves' Disease by Secreting Thyroid Autoantibodies and Cytokines.

Authors:  Yedi Cao; Xue Zhao; Ran You; Yang Zhang; Chenxue Qu; Youyuan Huang; Yang Yu; Yan Gong; Tiechuan Cong; Enmin Zhao; Lanbo Zhang; Ying Gao; Junqing Zhang
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

9.  Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and Hürthle cell neoplasms of the thyroid gland.

Authors:  Rok Petric; Hana Besic; Nikola Besic
Journal:  World J Surg Oncol       Date:  2014-09-12       Impact factor: 2.754

10.  Functional polymorphisms in antioxidant genes in Hurthle cell thyroid neoplasm - an association of GPX1 polymorphism and recurrent Hurthle cell thyroid carcinoma.

Authors:  Blaz Krhin; Katja Goricar; Barbara Gazic; Vita Dolzan; Nikola Besic
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.